BE Seminar: “Robust CRISPR/Cas-based epigenome editing technologies for precision human cell engineering and mechanistic dissection of pathological gene expression” (Isaac Hilton, Rice University)
/
216 Moore Building
Recent advances in CRISPR/Cas-based epigenome editing technologies have enabled programmable control over human gene expression, chromatin states, and genomic organization. Consequently, these emerging technologies have created new opportunities to engineer human cells for therapeutic benefit and catalyzed innovative ways to functionally interrogate gene regulatory mechanisms in situ. Toward these ends, we have recently developed new […]